Pacer Advisors
SANA icon

Pacer Advisors’s Sana Biotechnology SANA Stock Holding History

Pacer Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+3,286
New +$10.6K ﹤0.01% 2341
2024
Q3 		– Sell
-1,936
Closed -$10.6K – 2680
2024
Q2 		$10.6K Sell
1,936
-373
-16% -$2.97K ﹤0.01% 3540
2024
Q1 		$23.1K Buy
+2,309
New +$17.3K ﹤0.01% 3419

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Pacer Advisors's SANA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Sana Biotechnology (SANA) in Q2 2026: 3,286 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2341 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in SANA as recently as Q2 2024.

Pacer Advisors first reported a position in SANA in Q1 2024 and has held it in 3 quarters since. The position peaked at $23.1K in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Pacer Advisors held 3,286 shares of Sana Biotechnology worth $11K as of Q2 2026.
  • Sana Biotechnology was a new Pacer Advisors position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2341 holding.
  • Pacer Advisors first reported a position in Sana Biotechnology in Q1 2024 and has held it in 3 quarters since.
  • Pacer Advisors's Sana Biotechnology position peaked at $23.1K in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.